Serious Long-Term Effects of Head and Neck Cancer from the Survivors’ Point of View
Kathy Taylor(Johannes Gutenberg University Mainz), Susanne Singer(Rostock University of Music and Theatre), Monica Pinto(Jagiellonian University), Alberto Paderno(Humanitas University), Ricardo Ribeiro Gama(Hospital de Câncer de Barretos), Tatiana Dragan(Université Libre de Bruxelles), Joaquim Castro Silva(Instituto Português de Oncologia Francisco Gentil), Michaela Plath(Heidelberg University), Bente Brokstad Herlofson(Oslo University Hospital), Melissa Scricciolo(Ospedale dell' Angelo), Alexander Fabian(University Hospital Schleswig-Holstein), Pietro Perotti(Provincia Autonoma di Trento), Giuseppe Fanetti(Centro di Riferimento Oncologico), Naomi Kiyota(Kobe University Hospital), Maria Kouri(National and Kapodistrian University of Athens), Ayman Bushnak(Universitätsklinikum Gießen und Marburg), Femke Jansen(Vrije Universiteit Amsterdam), Sandra Nuyts(Cancer Institute (WIA)), Irma M. Verdonck‐de Leeuw(Amsterdam University Medical Centers), Pierluigi Bonomo(Azienda Ospedaliero-Universitaria Careggi), Kristin Bjordal(Norwegian Cancer Society), Eva Hammerlid(Sahlgrenska University Hospital), Francesco Tramacere(ASL Roma), Andreas Boehm(Klinikum St. Georg), Maximilian Krüger(Johannes Gutenberg University Mainz), Cecilie Delphin Amdal(Oslo University Hospital), Orlando Guntinas‐Lichius(Jena University Hospital), Alexandre Arthur Jacinto(Hospital de Câncer de Barretos), Johanna Inhestern, Ulrike Wöhner(Klinikum St. Georg), Guro Lindviksmoen Astrup(Oslo University Hospital), Carmen Stromberger(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Fréderic Duprez(Ghent University Hospital), Noa Stempler(Sheba Medical Center)
Cited by 35
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
EORTC QLQ-C30 Scoring Manual
|Research at the University of Copenhagen (University of Copenhagen)|1995|2.4k
ESHRE guideline: endometriosis
|Human Reproduction Open|2022|1.5k
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
|Oral Oncology|2018|802
Impact of Late Treatment-Related Toxicity on Quality of Life Among Patients With Head and Neck Cancer Treated With Radiotherapy
|Journal of Clinical Oncology|2008|687